ARCHIVES

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

CTEP’s Clinical Trials Proposals Reshaped By Discussion: BSC Next On Schedule

May 9, 1986

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994